title: Urinary tract carcinoma in leprosy patients treated with dapsone for a long period.
authors.forename: K
authors.initials: K
authors.lastname: Hironaka
authors.forename: M
authors.initials: M
authors.lastname: Mizushima
authors.forename: C
authors.initials: C
authors.lastname: Tsuzi
authors.forename: H
authors.initials: H
authors.lastname: Makino
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000700:Analgesics / Q000008:administration & dosage / Q000009:adverse effects; D003622:Dapsone / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007917:Leprostatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010615:Phenacetin / Q000008:administration & dosage / Q000009:adverse effects; D013997:Time Factors; D014571:Urologic Neoplasms / Q000139:chemically induced*
chemical_list: D000700:Analgesics; D007917:Leprostatic Agents; D003622:Dapsone; D010615:Phenacetin